Neuromuscular Nondepolarizing Agents
"Neuromuscular Nondepolarizing Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants.
Descriptor ID |
D003473
|
MeSH Number(s) |
D27.505.696.663.700.710.575
|
Concept/Terms |
Neuromuscular Nondepolarizing Agents- Neuromuscular Nondepolarizing Agents
- Agents, Neuromuscular Nondepolarizing
- Nondepolarizing Agents, Neuromuscular
- Curariform Drugs
- Drugs, Curariform
- Nondepolarizing Blockers
- Blockers, Nondepolarizing
- Neuromuscular Blocking Agents, Competitive
- Curare-Like Agents
- Agents, Curare-Like
- Curare Like Agents
- Muscle Relaxants, Non-Depolarizing
- Muscle Relaxants, Non Depolarizing
- Non-Depolarizing Muscle Relaxants
|
Below are MeSH descriptors whose meaning is more general than "Neuromuscular Nondepolarizing Agents".
Below are MeSH descriptors whose meaning is more specific than "Neuromuscular Nondepolarizing Agents".
This graph shows the total number of publications written about "Neuromuscular Nondepolarizing Agents" by people in this website by year, and whether "Neuromuscular Nondepolarizing Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neuromuscular Nondepolarizing Agents" by people in Profiles.
-
The risk of anaphylactic reactions to rocuronium in the United States is comparable to that of vecuronium: an analysis of food and drug administration reporting of adverse events. Anesth Analg. 2005 Sep; 101(3):819-822.